Clinical Phase I study with an Insulin-like Growth Factor-1 Receptor Inhibitor: Experiences in patients with squamous non-small cell lung carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinical Phase I study with an Insulin-like Growth Factor-1 Receptor Inhibitor: Experiences in patients with squamous non-small cell lung carcinoma

Published:2010-08-11 Issue:3 Volume:50 Page:441-447
ISSN:0284-186X
Container-title:Acta Oncologica
language:en
Short-container-title:Acta Oncologica

Author:

Ekman Simon,Frödin Jan-Erik,Harmenberg Johan,Bergman Antonina,Hedlund Åsa,Dahg Pia,Alvfors Carina,Ståhl Birgitta,Bergström Stefan,Bergqvist Michael

Publisher

Informa UK Limited

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.3109/0284186X.2010.499370

Reference13 articles.

1. Insulin and insulin-like growth factor signalling in neoplasia

2. Clinical Development of Inhibitors of the Insulin-like Growth Factor Receptor in Oncology

3. Emerging role of insulin-like growth factor receptor inhibitors in oncology: early clinical trial results and future directions

4. Cyclolignans as Inhibitors of the Insulin-Like Growth Factor-1 Receptor and Malignant Cell Growth

5. IGF-1 receptor tyrosine kinase inhibition by the cyclolignan PPP induces G2/M-phase accumulation and apoptosis in multiple myeloma cells

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting HSP90 with picropodophyllin suppresses gastric cancer tumorigenesis by disrupting the association of HSP90 and AKT;Phytotherapy Research;2023-08-09

2. PET morphology helps distinguish solitary and solid pulmonary tuberculosis from non-small cell lung cancer;Japanese Journal of Radiology;2022-10-13

3. Different Roles of the Insulin-like Growth Factor (IGF) Axis in Non-small Cell Lung Cancer;Current Pharmaceutical Design;2022-07

4. Biology and pathophysiology of central nervous system metastases;Neurological Complications of Systemic Cancer and Antineoplastic Therapy;2022

5. Oncogenic State and Cell Identity Combinatorially Dictate the Susceptibility of Cells within Glioma Development Hierarchy to IGF1R Targeting;Advanced Science;2020-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3